{"id":1677,"date":"2021-10-14T16:30:33","date_gmt":"2021-10-14T07:30:33","guid":{"rendered":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/?page_id=1677"},"modified":"2022-06-29T13:29:32","modified_gmt":"2022-06-29T04:29:32","slug":"test","status":"publish","type":"page","link":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/test\/","title":{"rendered":"\u6cbb\u9a13\u306b\u53c2\u52a0\u3044\u305f\u3060\u3051\u308b\u65b9\uff08TEST)"},"content":{"rendered":"\n

\u5f53\u30bb\u30f3\u30bf\u30fc\u306e\u53d7\u8a3a\u65b9\u6cd5<\/span><\/h2><\/div><\/div>\n\n\n\n

\u6cbb\u9a13\u306e\u53c2\u52a0\u306b\u95a2\u3059\u308b\u304a\u554f\u3044\u5408\u308f\u305b\u306b\u306f\u3001\u6cbb\u7642\u7d4c\u904e\u306a\u3069\u306e\u8a73\u3057\u3044\u533b\u7642\u60c5\u5831\u304c\u5fc5\u8981\u306b\u306a\u308a\u307e\u3059\u3002
\u305d\u306e\u305f\u3081\u3001
\u2460\u60a3\u8005\u3055\u3093\u306f\u3001\u4e3b\u6cbb\u533b\u306b\u5f53\u30bb\u30f3\u30bf\u30fc\u53d7\u8a3a\u5e0c\u671b\u306b\u3064\u3044\u3066\u76f8\u8ac7\u3057\u3066\u304f\u3060\u3055\u3044\u3002
\u2461\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u65b9\u306f\u3001\u4e0b\u8a18\u3088\u308a\u53d7\u8a3a\u306e\u554f\u3044\u5408\u308f\u305b\u3092\u304a\u9858\u3044\u3044\u305f\u3057\u307e\u3059\u3002
<\/p>\n\n\n\n

<\/i>\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u65b9\u3078<\/span><\/a><\/div>\n\n\n\n
<\/div>
<\/div>
<\/div><\/div>\n\n\n\n

\u5b9f\u65bd\u4e2d\u306e\u6cbb\u9a13\u4e00\u89a7<\/span><\/h2><\/div><\/div>\n\n\n\n

\u304c\u3093\u7814\u6709\u660e\u75c5\u9662\u5148\u7aef\u533b\u7642\u958b\u767a\u30bb\u30f3\u30bf\u30fc\u3067\u5b9f\u65bd\u3057\u3066\u3044\u308b\u6cbb\u9a13\u306e\u60c5\u5831\u3092\u3054\u7d39\u4ecb\u3057\u3066\u3044\u307e\u3059\u3002\uff08\u304c\u3093\u7814\u6709\u660e\u75c5\u9662\u5168\u4f53\u3067\u5b9f\u65bd\u3057\u3066\u3044\u308b\u6cbb\u9a13\u306e\u60c5\u5831\u3067\u306f\u3042\u308a\u307e\u305b\u3093\uff09
\u672c\u30da\u30fc\u30b8\u3067\u306f\u3001\u6cbb\u9a13\u958b\u59cb\u6642\u70b9\u3067\u306e\u5185\u5bb9\u3092\u8a18\u8f09\u3057\u3066\u3044\u308b\u305f\u3081\u3001\u65b0\u3057\u3044\u60c5\u5831\u304c\u542b\u307e\u308c\u3066\u3044\u306a\u3044\u5834\u5408\u3084\u3059\u3067\u306b\u52df\u96c6\u3092\u7d42\u4e86\u3057\u3066\u3044\u308b\u6cbb\u9a13\u304c\u8868\u793a\u3055\u308c\u3066\u3044\u308b\u5834\u5408\u304c\u3042\u308b\u3053\u3068\u3092\u3054\u4e86\u627f\u304f\u3060\u3055\u3044\u3002<\/u><\/p>\n\n\n\n

\u66f4\u65b0\u65e5\uff1a2021\u5e7410\u670829\u65e5<\/p>\n\n\n\n

\n\n\n\n
\u5bfe\u8c61\u764c\u7a2e<\/nobr><\/th>\u5bfe\u8c61\u60a3\u8005<\/nobr><\/th>\u6cbb\u9a13\u8ab2\u984c\u540d<\/nobr><\/th>\u6cbb\u9a13\u85ac<\/nobr>
\u4f5c\u7528\u6a5f\u5e8f\u7b49<\/nobr><\/th>		\u958b\u767a\u76f8<\/nobr><\/th>\u767b\u9332\u72b6\u6cc1<\/nobr><\/th>\u8cac\u4efb<\/nobr>
\u533b\u5e2b<\/nobr><\/th>		\u8a66\u9a13\u767b\u9332<\/nobr>
\uff08\u767b\u9332\u756a\u53f7\uff09<\/nobr><\/th>		\u7ba1\u7406<\/nobr>
\u756a\u53f7<\/nobr><\/th>\n<\/tr>\n<\/thead>\n
\u4e73\u764c<\/td>HR\u967d\u6027\u304b\u3064HER2\u9670\u6027\u4e73\u764c<\/td>\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u30ec\u30bb\u30d7\u30bf\u30fc\u967d\u6027\u53ca\u3073HER2 \u9670\u6027\u4e73\u764c\u306e\u65e5\u672c\u4eba\u5973\u6027\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fH3B-6545 \u306e\u81e8\u5e8a\u7b2c1\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5c0f\u91ce\u9ebb\u7d00\u5b50<\/td>JAPIC
\uff08JapicCTI-205456\uff09
ClinicalTrials.gov
\uff08NCT04568902\uff09<\/td>		2020-0028<\/td><\/tr>
\u9032\u884c\/\u518d\u767a\u53c8\u306f\u8ee2\u79fb\u4e73\u304c\u3093<\/td>\u30a8\u30b9\u30c8\u30ed\u30b2\u30f3\u53d7\u5bb9\u4f53\u967d\u6027HER2\u9670\u6027\u4e73\u304c\u3093<\/td>\u30a8\u30fc\u30b6\u30a4\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c1b\u76f8\u8a66\u9a13<\/td>FGFR\u963b\u5bb3\u5264<\/td>\u2160b<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>JAPIC
\uff08JapicCTI-205429\uff09<\/td>		2020-0035<\/td><\/tr>
HER2\u9670\u6027\u80c3\/\u80c3\u98df\u9053\u63a5\u5408\u90e8\u764c\u3001\u98df\u9053\u764c\u3001\u5c3f\u8def\u4e0a\u76ae\uff08\u79fb\u884c\u4e0a\u76ae\uff09\u764c<\/td>\u2015<\/td>\u9032\u884c\u56fa\u5f62\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fDS-1062a\u3092\u8907\u6570\u7528\u91cf\u7528\u3044\u308b\u591a\u65bd\u8a2d\u5171\u540c\u975e\u76f2\u691c2\u30d1\u30fc\u30c8\u7b2c1\u76f8first in human\u8a66\u9a13<\/td>\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53
\uff08\u6297TROP2\u6297\u4f53-\u30c8\u30dd\u30a4\u30bd\u30e1\u30e9\u30fc\u30bc\u963b\u5bb3\u85ac\uff09
<\/td>		\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>JAPIC
\uff08JapicCTI-173812\uff09
ClinicalTrials.gov \uff08NCT03401385\uff09<\/td>		2020-0036<\/td><\/tr>
\u4e73\u304c\u3093<\/td>\u2015<\/td>\u56fd\u969b\u5171\u540c\u6cbb\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>ClinicalTrials.gov
\uff08NCT02926690\uff09<\/td>		2020-0063<\/td><\/tr>
\u9032\u884c\u30fb\u518d\u767a\u56fa\u5f62\u764c<\/td>\u2015<\/td>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>\u2015<\/td>2020-0064<\/td><\/tr>
\u81b5\u304c\u3093<\/td>\u5316\u5b66\u7642\u6cd5\u672a\u6cbb\u7642\u304b\u3064\u9060\u9694\u8ee2\u79fb\u3092\u6709\u3059\u308b\u81b5\u304c\u3093<\/td>ONO-4578 \u7b2c\u2160\u76f8\u8a66\u9a13
 \u9060\u9694\u8ee2\u79fb\u3092\u6709\u3059\u308b\u81b5\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u4e00\u6b21\u6cbb\u7642\u3068\u3057\u3066ONO-4578\u3001ONO-4538 \u4e26\u3073\u306b\u6a19\u6e96\u6cbb\u7642\u3067\u3042\u308bmodified FOLFIRINOX\uff08mFFX\uff09\u7642\u6cd5\u53c8\u306f\u30b2\u30e0\u30b7\u30bf\u30d3\u30f3\u53ca\u3073\u30ca\u30d6\u30d1\u30af\u30ea\u30bf\u30ad\u30bb\u30eb\uff08GnP\uff09\u7642\u6cd5\u3092\u4f75\u7528\u3059\u308b\u975e\u76f2\u691c\u975e\u5bfe\u7167\u8a66\u9a13<\/td>		\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>jRCT
\uff08jRCT2031200286\uff09<\/td>		2020-0065<\/td><\/tr>
\u5207\u9664\u4e0d\u80fd\u53c8\u306f\u8ee2\u79fb\u6027\u96e3\u6cbb\u6027\u56fa\u5f62\u816b\u760d<\/td>NRAS\/KRAS\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027<\/td>NRAS\/KRAS\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027\u306e\u65e5\u672c\u4eba\u9032\u884c\u3001\u5207\u9664\u4e0d\u80fd\u53c8\u306f\u8ee2\u79fb\u6027\u96e3\u6cbb\u6027\u56fa\u5f62\u816b\u760d\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3059\u308bBI 3011441\u306e\u7b2cI\u76f8\u975e\u76f2\u691c\u8a66\u9a13<\/td>MEK\u963b\u5bb3\u5264<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>mystudywindow
(BI 1469-0002)
jRCT
(jRCT2031200249)
ClinicalTrials.gov
(NCT04742556)<\/td>		2020-0070<\/td><\/tr>
\u9032\u884c\u4e73\u764c<\/td>\u2015<\/td>\u65e5\u672c\u4eba\u5973\u6027\u306eER\u967d\u6027HER2\u9670\u6027\u9032\u884c\u4e73\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u3066\u3001AZD9833 \u306e\u5b89\u5168\u6027\u3001\u5fcd\u5bb9\u6027\u3001\u85ac\u7269\u52d5\u614b\u53ca\u3073\u6297\u816b\u760d\u52b9\u679c\u3092\u8a55\u4fa1\u3059\u308b\u975e\u76f2\u691c\u7b2cI\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>JAPIC
(JapicCTI-205469)
ClinicalTrials.gov
(NCT04541433)<\/td>		2020-0071<\/td><\/tr>
\u5b50\u5bae\u9838\u764c<\/td>\u518d\u767a\u53c8\u306f\u8ee2\u79fb\u6027\u5b50\u5bae\u9838\u764c<\/td>\u30d7\u30e9\u30c1\u30ca\u7cfb\u5316\u5b66\u7642\u6cd5\u306e\u5b9f\u65bd\u4e2d\u53c8\u306f\u5b9f\u65bd\u5f8c\u306b\u75c5\u52e2\u9032\u884c\u304c\u8a8d\u3081\u3089\u308c\u305f\u518d\u767a\u53c8\u306f\u8ee2\u79fb\u6027\u5b50\u5bae\u9838\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30da\u30e0\u30d6\u30ed\u30ea\u30ba\u30de\u30d6\u53ca\u3073\u30aa\u30e9\u30d1\u30ea\u30d6\u4f75\u7528\u7642\u6cd5\u306e\u7b2cII\u76f8\u8a66\u9a13\uff08\u533b\u5e2b\u4e3b\u5c0e\u6cbb\u9a13\uff09
<\/td>		PD-1\u6297\u4f53,PARP\u963b\u5bb3\u5264<\/td>\u2161<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>\u3000
jRCT
(jRCT2031210096)
ClinicalTrials.gov
(NCT04641728)<\/td>		2020-0087<\/td><\/tr>
\u9032\u884c\u56fa\u5f62\u764c<\/td>\u6a19\u6e96\u7684\u6cbb\u7642\u6cd5\u306b\u4e0d\u5fdc\u53c8\u306f\u4e0d\u8010\u3068\u306a\u3063\u305f\u3001\u3082\u3057\u304f\u306f\u6a19\u6e96\u7684\u6cbb\u7642\u6cd5\u304c\u306a\u3044\u60a3\u8005<\/td>\u9032\u884c\u56fa\u5f62\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fDS-7300a \u306e\u591a\u65bd\u8a2d\u5171\u540c2\u30d1\u30fc\u30c8\u7b2cI\/II \u76f8 First-in-Human\u8a66\u9a13
<\/td>		\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53
\uff08\u6297B7-H3\u6297\u4f53-\u30c8\u30dd\u30a4\u30bd\u30e1\u30e9\u30fc\u30bc\u2160\u963b\u5bb3\u85ac\uff09
<\/td>		\u2160\/\u2161<\/td>\u767b\u9332\u4e2d<\/td>\u9ad9\u6a4b\u4fca\u4e8c<\/td>JAPIC
\uff08JapicCTI-194992\uff09
ClinicalTrial.gov
\uff08NCT04145622\uff09<\/td>		2021-0005<\/td><\/tr>
KRAS\u5909\u7570\u967d\u6027\u56fa\u5f62\u764c\uff08\u30d1\u30fc\u30c8A\u53ca\u3073B\uff09
KRAS\u5909\u7570\u967d\u6027NSCLC\u53ca\u3073CRC\uff08\u30d1\u30fc\u30c8C\u53ca\u3073D\uff09
<\/td>		KRAS\u907a\u4f1d\u5b50\u5909\u7570\u967d\u6027<\/td>KRAS\u5909\u7570\u578b\u9032\u884c\u53c8\u306f\u8ee2\u79fb\u6027\u56fa\u5f62\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fBI 1701963\u5358\u5264\u7642\u6cd5\u53ca\u3073BI 3011441\u3068\u306e\u4f75\u7528\u7642\u6cd5\u3092\u691c\u8a0e\u3059\u308b\u7b2cI\u76f8\u975e\u76f2\u691c\u7528\u91cf\u6f38\u5897\u8a66\u9a13<\/td>KRAS-SOS1\u963b\u5bb3\u5264\uff0cMEK\u963b\u5bb3\u5264<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>mystudywindow
\uff08BI 1432-0006\uff09
jRCT
\uff08jRCT2031200385\uff09
ClinicalTrials.gov
\uff08NCT04835714\uff09<\/td>		2021-0006<\/td><\/tr>
\u80c3\u764c<\/td>\u2015<\/td>\u2015<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>jRCT
\uff08jRCT2031210025\uff09
ClinicalTrials.gov
\uff08NCT03564691\uff09
<\/td>		2021-0007<\/td><\/tr>
\u81b5\u304c\u3093<\/td>\u5316\u5b66\u7642\u6cd5\u672a\u6cbb\u7642\u304b\u3064\u9060\u9694\u8ee2\u79fb\u3092\u6709\u3059\u308b\u81b5\u304c\u3093<\/td>ONO-7913 \u7b2c\u2160\u76f8\u8a66\u9a13
\u9060\u9694\u8ee2\u79fb\u3092\u6709\u3059\u308b\u81b5\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u4e00\u6b21\u6cbb\u7642\u3068\u3057\u3066ONO-7913 \u53ca\u3073ONO-4538 \u3092\u6a19\u6e96\u6cbb\u7642\u3067\u3042\u308bmodified FOLFIRINOX \u7642\u6cd5\u3068\u4f75\u7528\u3059\u308b\u975e\u76f2\u691c\u975e\u5bfe\u7167\u8a66\u9a13<\/td>		\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>
jRCT
(jRCT2031210172)<\/td>		2021-0028<\/td><\/tr>
\u9032\u884c\uff0f\u518d\u767a\u6de1\u660e\u7d30\u80de\u578b\u814e\u7d30\u80de\u764c\u3001\u4f4e\u9178\u7d20\u8a98\u56e0\u56e0\u5b502\u03b1\u5b89\u5b9a\u5316\u5909\u7570\u3092\u6709\u3059\u308b\u60aa\u6027\u816b\u760d<\/td>\u2015<\/td>\u30ce\u30d0\u30eb\u30c6\u30a3\u30b9 \u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160\/\u2160b<\/td>\u767b\u9332\u4e2d<\/td>\u9ad9\u6a4b\u4fca\u4e8c<\/td>
jRCT
(jRCT2031210239)<\/td>		2021-0029<\/td><\/tr>
\u4e73\u304c\u3093<\/td>ER \u967d\u6027\u3001PgR \u967d\u6027\u304b\u3064HER2 \u9670\u6027\u306e\u4e73\u304c\u3093<\/td>\u5c0f\u91ce\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13
<\/td>		\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>
jRCT
(jRCT2031210364)<\/td>		2021-0037<\/td><\/tr>
\u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u53c8\u306f\u518d\u767a\u306e\u56fa\u5f62\u304c\u3093<\/td>\u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u53c8\u306f\u518d\u767a\u306e\u56fa\u5f62\u304c\u3093\u306e\u60a3\u8005\u3055\u3093<\/td>\u5c0f\u91ce\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>
jRCT
(jRCT2031210373)<\/td>		2021-0049<\/td><\/tr>
\u56fa\u5f62\u304c\u3093\u3001\u30c8\u30ea\u30d7\u30eb\u30cd\u30ac\u30c6\u30a3\u30d6\u4e73\u304c\u3093<\/td>\u2015<\/td>\u30ae\u30ea\u30a2\u30c9\u30fb\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u65e5\u672c\u4eba\u9032\u884c\u56fa\u5f62\u304c\u3093\u60a3\u8005\u53c8\u306f\u30c8\u30ea\u30d7\u30eb\u30cd\u30ac\u30c6\u30a3\u30d6\u4e73\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fSacituzumab Govitecan\u306e\u7b2c1\/2\u76f8\u8a66\u9a13<\/td>\u30c8\u30dd\u30a4\u30bd\u30e1\u30e9\u30fc\u30bc\u2160\u963b\u5bb3\u5264\uff08\u6297\u4f53\u85ac\u7269\u8907\u5408\u4f53\uff09<\/td>\u2160\/\u2161<\/td>\u767b\u9332\u4e2d<\/td>\u53e4\u5ddd\u5b5d\u5e83<\/td>jRCT
(jRCT2031210346)<\/td>		2021-0050<\/td><\/tr>
\u56fa\u5f62\u764c<\/td>\u9032\u884c\u56fa\u5f62\u764c\u60a3\u8005<\/td>\u56fa\u5f62\u764c\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fTAS-115 \u3068\u30d4\u30aa\u30b0\u30ea\u30bf\u30be\u30f3\/\u30ed\u30b5\u30eb\u30bf\u30f3\/\u30df\u30c0\u30be\u30e9\u30e0\u3068\u306e\u85ac\u7269\u76f8\u4e92\u4f5c\u7528\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u9ad9\u6a4b\u4fca\u4e8c<\/td>jRCT
(jRCT2031210372)<\/td>		2021-0054<\/td><\/tr>
\u56fa\u5f62\u304c\u3093<\/td>\u5207\u9664\u4e0d\u80fd\u306a\u9032\u884c\u53c8\u306f\u518d\u767a\u306e\u56fa\u5f62\u304c\u3093<\/td>\u5c0f\u91ce\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>jRCT
jRCT2031210530<\/td>		2021-0010<\/td><\/tr>
\u4e73\u764c\u3001\u5375\u5de3\u764c\u3001\u524d\u7acb\u817a\u764c\u3001\u81b5\u81d3\u764c<\/td>BRACA1\/2\u3001PALB2\u3082\u3057\u304f\u306fRAD51C\/D\u967d\u6027\u306e\u9032\u884c\u56fa\u5f62\u764c<\/td>\u9032\u884c\u56fa\u5f62\u304c\u3093\u60a3\u8005\u3092\u5bfe\u8c61\u306bAZD5305 \u3092\u5358\u5264\u53ca\u3073\u6297\u304c\u3093\u5264\u3068\u306e\u4f75\u7528\u3067\u7528\u91cf\u6f38\u5897\u6295\u4e0e\u3057\u305f\u3068\u304d\u306e\u5b89\u5168\u6027\u3001\u5fcd\u5bb9\u6027\u3001\u85ac\u7269\u52d5\u614b\u3001\u85ac\u529b\u5b66\u53ca\u3073\u4e88\u5099\u7684\u6709\u52b9\u6027\u3092\u8a55\u4fa1\u3059\u308b\u30e2\u30b8\u30e5\u30fc\u30eb\u578b\u975e\u76f2\u691c\u591a\u65bd\u8a2d\u5171\u540c\u7b2cI \u76f8\uff0f\u524d\u671f\u7b2cII \u76f8\u8a66\u9a13\uff08PETRA\uff09<\/td>PARP\u963b\u5bb3\u5264<\/td>\u2160\/\u2161<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>\u2015<\/td>2021-0072<\/td><\/tr>
\u9032\u884c\u56fa\u5f62\u764c
\u80c3\u764c
\u98df\u9053\u80c3\u63a5\u5408\u90e8
\u5c3f\u8def\u4e0a\u76ae\u764c
\u975e\u5c0f\u7d30\u80de\u80ba\u764c
\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c<\/td>		\u2015<\/td>\u30d5\u30a1\u30a4\u30b6\u30fc\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2cI\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>
ClinicalTrials.gov Identifier: NCT05233436<\/td>		2021-0077<\/td><\/tr>
\u982d\u981a\u90e8\u764c
\u809d\u764c<\/td>		\u982d\u981a\u90e8\u764c
\u809d\u764c<\/td>		\u65e5\u672c\u30d9\u30fc\u30ea\u30f3\u30ac\u30fc\u30a4\u30f3\u30b2\u30eb\u30cf\u30a4\u30e0\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160b<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>\u2015<\/td>2021-0078<\/td><\/tr>
\u56fa\u5f62\u764c<\/td>RET\u907a\u4f1d\u5b50\u7570\u5e38\u3092\u6709\u3059\u308b\u9032\u884c\u56fa\u5f62\u764c<\/td>\u5927\u9d6c\u85ac\u54c1\u5de5\u696d\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u9ad9\u6a4b\u3000\u4fca\u4e8c<\/td>clinicalTrials. Gov
\uff08NCT04683250\uff09
jRCT
\uff08jRCT2031200208\uff09<\/td>		2021-0080<\/td><\/tr>
\u2015<\/td>\u2015<\/td>\u30a4\u30f3\u30b5\u30a4\u30c8\u30fb\u30d0\u30a4\u30aa\u30b5\u30a4\u30a8\u30f3\u30b7\u30ba\u30fb\u30b8\u30e3\u30d1\u30f3\u5408\u540c\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308b\u7b2c\u2160\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160<\/td>\u767b\u9332\u4e2d<\/td>\u5317\u91ce\u6ecb\u4e45<\/td>ClinicalsTrial.gov:NCT05238922
jRCT:jRCT2031220091<\/td>		2022-0001<\/td><\/tr>
\u56fa\u5f62\u304c\u3093<\/td>FGFR2b\u3092\u904e\u5270\u767a\u73fe\u3057\u3066\u3044\u308b\u56fa\u5f62\u304c\u3093<\/td>\u30a2\u30e0\u30b8\u30a7\u30f3\u682a\u5f0f\u4f1a\u793e\u306e\u4f9d\u983c\u306b\u3088\u308bAMG 552 (Bemarituzumab) \u306e\u7b2cIb\/II\u76f8\u8a66\u9a13<\/td>\u2015<\/td>\u2160b\/\u2161<\/td>\u767b\u9332\u4e2d<\/td>\u9ad9\u6a4b\u3000\u4fca\u4e8c<\/td>jRCT\uff08\u767b\u9332\u756a\u53f7\u672a\u5b9a\uff09<\/td>2022-0009<\/td><\/tr>\n<\/tbody>\n<\/table><\/figure>\n\n\n\n

\u203b\u300c\u767b\u9332\u4e2d\u300d\u306e\u5834\u5408\u3067\u3082\u3059\u3067\u306b\u52df\u96c6\u3092\u7d42\u4e86\u3057\u3066\u3044\u308b\u6cbb\u9a13\u304c\u8868\u793a\u3055\u308c\u3066\u3044\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u6cbb\u9a13\u306e\u53c2\u52a0\u306b\u95a2\u3059\u308b\u304a\u554f\u3044\u5408\u308f\u305b\u306b\u306f\u3001\u6cbb\u7642\u7d4c\u904e\u306a\u3069\u306e\u8a73\u3057\u3044\u533b\u7642\u60c5\u5831\u304c\u5fc5\u8981\u306b\u306a\u308a\u307e\u3059\u3002\u305d\u306e\u305f\u3081\u3001\u2460\u60a3\u8005\u3055\u3093\u306f\u3001\u4e3b\u6cbb\u533b\u306b\u5f53\u30bb\u30f3\u30bf\u30fc\u53d7\u8a3a\u5e0c\u671b\u306b\u3064\u3044\u3066\u76f8\u8ac7\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u2461\u4e3b\u6cbb\u533b\u306e\u5148\u751f\u65b9\u306f\u3001\u4e0b\u8a18\u3088\u308a\u53d7\u8a3a\u306e\u554f\u3044\u5408\u308f\u305b\u3092\u304a\u9858\u3044\u3044\u305f\u3057\u307e\u3059 […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/pages\/1677"}],"collection":[{"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/comments?post=1677"}],"version-history":[{"count":88,"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/pages\/1677\/revisions"}],"predecessor-version":[{"id":1943,"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/pages\/1677\/revisions\/1943"}],"wp:attachment":[{"href":"https:\/\/plaza.umin.ac.jp\/~C4AMD\/wp-json\/wp\/v2\/media?parent=1677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}